RAFAEL HOLDINGS, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- RAFAEL HOLDINGS, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-07-31 was $0.00.
- RAFAEL HOLDINGS, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-04-30 was $360.00K.
- RAFAEL HOLDINGS, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-07-31 was $28.00K.
- RAFAEL HOLDINGS, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-04-30 was $0.00, a 100.00% decline year-over-year.
- RAFAEL HOLDINGS, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $360.00K.
- RAFAEL HOLDINGS, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $71.00K, a 144.83% increase from fiscal 2020.
- RAFAEL HOLDINGS, INC. stock issued during period, value, stock options exercised for fiscal 2020 was $29.00K, a 84.74% decline from fiscal 2019.
- RAFAEL HOLDINGS, INC. stock issued during period, value, stock options exercised for fiscal 2019 was $190.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $360.00K 10-K · filed 2025-10-29 |
| 2025-04-30 | $360.00K 10-Q · filed 2025-06-11 | |
| 2021-07-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | $71.00K 10-K · filed 2022-10-31 |
| 2021-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-06-14 | $43.00K derived: sum of 4 quarters · filed 2022-06-14 |
| 2021-01-31 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2022-03-17 | $72.00K derived: sum of 4 quarters · filed 2022-03-17 |
| 2020-10-31 | $43.00K 10-Q/A · filed 2022-02-28 | |
| 2020-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-18 | $29.00K 10-K · filed 2021-10-18 |
| 2020-04-30 | $29.00K 10-Q · filed 2021-06-14 | |
| 2019-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-29 | $190.00K 10-K · filed 2020-10-29 |
| 2019-04-30 | $27.00K 10-Q · filed 2020-06-09 | |
| 2019-01-31 | $45.00K 10-Q · filed 2020-03-05 | |
| 2018-10-31 | $118.00K 10-Q · filed 2019-12-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |